Development of HER2-antagonistic peptides as novel anti-breast cancer drugs by in silico methods

• NAKAJIMA Hiroo

  Department of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine

• MIZUTA Naruhiko

  Department of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine

• SAKAGUCHI Koichi

  Department of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine

• FUJIWARA Ikuya

  Department of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine

• YOSHIMORI Atsushi

  Institute for Theoretical Medicine, Inc.

• TAKAHASHI Satoshi

  Institute for Theoretical Medicine, Inc.

• TAKASAWA Ryoko

  Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science

• TANUMA Sei-ichi

  Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science

収録刊行物

• Breast cancer : the journal of the Japanese Breast Cancer Society

  Breast cancer : the journal of the Japanese Breast Cancer Society 15 (1), 65-72, 2008-01-01

キーワード

• HER2
• Breast cancer
• In silico drug design method
• Antagonistic peptide
• Monoclonal antibody

詳細情報

• CRID: 1570854175595086848
• NII論文ID: 10021288506
• NII書誌ID: AA1103354X
• ISSN: 13406868
• Web Site: https://search.jamas.or.jp/link/ui/2008187486
• 本文言語コード: en
• データソース種別:
  • CiNii Articles